SPAST expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.241000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
9.953600E-01
Normal-vs-Stage2
5.869400E-01
Normal-vs-Stage3
2.485700E-02
Normal-vs-Stage4
3.328800E-01
Stage1-vs-Stage2
4.510600E-01
Stage1-vs-Stage3
3.618100E-02
Stage1-vs-Stage4
4.026800E-01
Stage2-vs-Stage3
1.088820E-01
Stage2-vs-Stage4
1.587010E-01
Stage3-vs-Stage4
5.020600E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.031400E-01
Normal-vs-AfricanAmerican
7.516200E-01
Normal-vs-Asian
2.375000E-01
Caucasian-vs-AfricanAmerican
2.333600E-01
Caucasian-vs-Asian
4.868600E-01
AfricanAmerican-vs-Asian
9.095600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.749800E-01
Normal-vs-Female
5.758600E-01
Male-vs-Female
7.327000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.872200E-01
Normal-vs-Age(41-60Yrs)
9.754800E-01
Normal-vs-Age(61-80Yrs)
4.988600E-01
Normal-vs-Age(81-100Yrs)
3.740200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.347000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.666000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.634400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.931580E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.005600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.434000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.890960E-01
Normal-vs-Daily Drinker
3.132800E-01
Normal-vs-Weekly Drinker
4.312800E-01
Normal-vs-Occasional Drinker
9.814400E-01
Normal-vs-Social Drinker
8.578400E-01
Non Drinker-vs-Daily Drinker
9.759600E-01
Non Drinker-vs-Weekly Drinker
6.629800E-01
Non Drinker-vs-Occasional Drinker
2.865900E-02
Non Drinker-vs-Social Drinker
2.845200E-01
Daily Drinker-vs-Weekly Drinker
7.108800E-01
Daily Drinker-vs-Occasional Drinker
7.103700E-02
Daily Drinker-vs-Social Drinker
2.697400E-01
Weekly Drinker-vs-Occasional Drinker
2.032000E-01
Weekly Drinker-vs-Social Drinker
4.927400E-01
Occasional Drinker-vs-Social Drinker
7.422400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.942200E-02
Normal-vs-Grade 2
1.945820E-02
Normal-vs-Grade 3
2.022100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.264200E-01
Grade 1-vs-Grade 3
6.304600E-01
Grade 1-vs-Grade 4
8.942200E-02
Grade 2-vs-Grade 3
3.887600E-01
Grade 2-vs-Grade 4
1.945820E-02
Grade 3-vs-Grade 4
2.022100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.079800E-01
Normal-vs-NonDiabetic
4.594000E-01
Diabetic-vs-NonDiabetic
7.121000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.993980E-01
Normal-vs-NoPancreatitis
5.514800E-01
Pancreatitis-vs-NoPancreatitis
2.321200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.126200E-01
Normal-vs-N1
5.986200E-01
N0-vs-N1
6.999600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.389800E-01
Normal-vs-TP53-NonMutant
8.739000E-01
TP53-Mutant-vs-TP53-NonMutant
6.063000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
